MX2007006241A - 2-alcoxi-3,4,5-trihidroxi-alquilamidas, su preparacion, composiciones que las contienen y su utilizacion. - Google Patents
2-alcoxi-3,4,5-trihidroxi-alquilamidas, su preparacion, composiciones que las contienen y su utilizacion.Info
- Publication number
- MX2007006241A MX2007006241A MX2007006241A MX2007006241A MX2007006241A MX 2007006241 A MX2007006241 A MX 2007006241A MX 2007006241 A MX2007006241 A MX 2007006241A MX 2007006241 A MX2007006241 A MX 2007006241A MX 2007006241 A MX2007006241 A MX 2007006241A
- Authority
- MX
- Mexico
- Prior art keywords
- alcoxy
- alkylamides
- trihydroxy
- preparation
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
2-Alcoxi-3,4,5-trihidroxi-alquilamidas, su preparacion, composiciones que las contienen y utilizacion. La presente invencion se refiere notablemente a las 2-alcoxi-3,4,5-trihidroxi- alquilamidas, su preparacion, las composiciones que las contienen, y su utilizacion como un medicamento, en particular como agentes anti-cancerigeno.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0412645A FR2878528B1 (fr) | 2004-11-29 | 2004-11-29 | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
PCT/FR2005/002932 WO2006056696A2 (fr) | 2004-11-29 | 2005-11-25 | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007006241A true MX2007006241A (es) | 2007-07-25 |
Family
ID=34951749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007006241A MX2007006241A (es) | 2004-11-29 | 2005-11-25 | 2-alcoxi-3,4,5-trihidroxi-alquilamidas, su preparacion, composiciones que las contienen y su utilizacion. |
Country Status (22)
Country | Link |
---|---|
US (1) | US7550453B2 (es) |
EP (1) | EP1819679A2 (es) |
JP (1) | JP2008521780A (es) |
KR (1) | KR20070091120A (es) |
CN (1) | CN101065362A (es) |
AR (1) | AR052328A1 (es) |
AU (1) | AU2005308710A1 (es) |
BR (1) | BRPI0516666A (es) |
CA (1) | CA2595305A1 (es) |
CR (1) | CR9114A (es) |
EA (1) | EA011392B1 (es) |
FR (1) | FR2878528B1 (es) |
IL (1) | IL183044A0 (es) |
MA (1) | MA29030B1 (es) |
MX (1) | MX2007006241A (es) |
NO (1) | NO20073026L (es) |
PE (1) | PE20061121A1 (es) |
TN (1) | TNSN07137A1 (es) |
TW (1) | TW200630343A (es) |
UY (1) | UY29236A1 (es) |
WO (1) | WO2006056696A2 (es) |
ZA (1) | ZA200704342B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2878525B1 (fr) * | 2004-11-29 | 2007-02-23 | Aventis Pharma Sa | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation |
FR2901555A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation |
FR2901556A1 (fr) * | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation |
FR2901554B1 (fr) | 2006-05-24 | 2011-04-01 | Sanofi Aventis | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation |
CN101092384A (zh) * | 2006-06-22 | 2007-12-26 | 中国科学院上海药物研究所 | 一类α-氨基-N-取代酰胺化合物、其组合物及用途 |
CN101456824B (zh) * | 2007-12-11 | 2013-04-17 | 中国科学院上海药物研究所 | α-氨基-N-取代酰胺化合物、包含该化合物的药物组合物及其用途 |
EP2393781B1 (en) | 2008-12-23 | 2014-03-12 | F. Hoffmann-La Roche AG | Dihydropyridone ureas as p2x7 modulators |
CA2747925A1 (en) | 2008-12-23 | 2010-07-01 | F. Hoffmann-La Roche Ag | Dihydropyridone amides as p2x7 modulators |
WO2010072597A1 (en) | 2008-12-23 | 2010-07-01 | F. Hoffmann-La Roche Ag | Dihydropyridone amides as p2x7 modulators |
KR101370185B1 (ko) | 2008-12-23 | 2014-03-05 | 에프. 호프만-라 로슈 아게 | P2x7 조절제로서의 디히드로피리돈 아미드 |
US8153808B2 (en) | 2008-12-23 | 2012-04-10 | Roche Palo Alto Llc | Dihydropyridone amides as P2X7 modulators |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692522A (en) * | 1985-04-01 | 1987-09-08 | Merck & Co., Inc. | Benzofused lactams useful as cholecystokinin antagonists |
US4831135A (en) * | 1986-06-18 | 1989-05-16 | The Regents Of The University Of California | Bengamide anthelmintics |
US5283241A (en) * | 1992-08-28 | 1994-02-01 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
GB9411841D0 (en) | 1994-06-14 | 1994-08-03 | Pharma Mar Sa | New antitumoral compounds from jaspis sponge |
JP2002241368A (ja) | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
CO5140099A1 (es) * | 1998-11-17 | 2002-03-22 | Novartis Ag | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores |
US6239127B1 (en) * | 1999-11-17 | 2001-05-29 | Novartis Ag | Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation |
BR0110641A (pt) * | 2000-05-11 | 2003-03-18 | Novartis Ag | Determinados carbonatos e éteres caprolactâmicos substituìdos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de tumores |
WO2002039990A2 (en) * | 2000-11-14 | 2002-05-23 | Novartis Ag | Method for screening anti-proliferative compounds and inhibiting tumor growth |
US6545148B2 (en) * | 2001-03-12 | 2003-04-08 | Novartis Ag | Process for preparing certain substituted caprolactams |
JP2004262793A (ja) | 2003-02-28 | 2004-09-24 | Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai | 化合物n−9011、その製造法及び用途 |
JP2006528611A (ja) * | 2003-07-25 | 2006-12-21 | ノバルティス アクチエンゲゼルシャフト | 置換ラクタムおよびそれらの抗がん剤としての使用 |
US7153846B2 (en) * | 2003-10-24 | 2006-12-26 | Sanofi-Aventis Deutschland Gmbh | Bengamide derivatives, process for preparing them, and their use |
DE10349669B3 (de) | 2003-10-24 | 2005-05-25 | Aventis Pharma Deutschland Gmbh | Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
FR2878525B1 (fr) * | 2004-11-29 | 2007-02-23 | Aventis Pharma Sa | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation |
FR2901554B1 (fr) | 2006-05-24 | 2011-04-01 | Sanofi Aventis | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation |
FR2901556A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation |
FR2901555A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation |
-
2004
- 2004-11-29 FR FR0412645A patent/FR2878528B1/fr not_active Expired - Fee Related
-
2005
- 2005-11-22 PE PE2005001366A patent/PE20061121A1/es not_active Application Discontinuation
- 2005-11-25 CA CA002595305A patent/CA2595305A1/fr not_active Abandoned
- 2005-11-25 AR ARP050104935A patent/AR052328A1/es unknown
- 2005-11-25 CN CNA2005800407464A patent/CN101065362A/zh active Pending
- 2005-11-25 EA EA200701172A patent/EA011392B1/ru not_active IP Right Cessation
- 2005-11-25 BR BRPI0516666-7A patent/BRPI0516666A/pt not_active IP Right Cessation
- 2005-11-25 KR KR1020077012024A patent/KR20070091120A/ko not_active Application Discontinuation
- 2005-11-25 MX MX2007006241A patent/MX2007006241A/es active IP Right Grant
- 2005-11-25 EP EP05822934A patent/EP1819679A2/fr not_active Withdrawn
- 2005-11-25 AU AU2005308710A patent/AU2005308710A1/en not_active Withdrawn
- 2005-11-25 WO PCT/FR2005/002932 patent/WO2006056696A2/fr active Application Filing
- 2005-11-25 ZA ZA200704342A patent/ZA200704342B/en unknown
- 2005-11-25 JP JP2007542046A patent/JP2008521780A/ja active Pending
- 2005-11-28 TW TW094141645A patent/TW200630343A/zh unknown
- 2005-11-29 UY UY29236A patent/UY29236A1/es unknown
-
2007
- 2007-04-13 TN TNP2007000137A patent/TNSN07137A1/fr unknown
- 2007-05-07 IL IL183044A patent/IL183044A0/en unknown
- 2007-05-09 CR CR9114A patent/CR9114A/es not_active Application Discontinuation
- 2007-05-17 MA MA29917A patent/MA29030B1/fr unknown
- 2007-05-24 US US11/753,160 patent/US7550453B2/en not_active Expired - Fee Related
- 2007-06-13 NO NO20073026A patent/NO20073026L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2595305A1 (fr) | 2006-06-01 |
EP1819679A2 (fr) | 2007-08-22 |
MA29030B1 (fr) | 2007-11-01 |
CN101065362A (zh) | 2007-10-31 |
TW200630343A (en) | 2006-09-01 |
JP2008521780A (ja) | 2008-06-26 |
IL183044A0 (en) | 2007-09-20 |
US20070244087A1 (en) | 2007-10-18 |
AR052328A1 (es) | 2007-03-14 |
CR9114A (es) | 2008-01-21 |
ZA200704342B (en) | 2008-07-30 |
PE20061121A1 (es) | 2006-11-10 |
FR2878528B1 (fr) | 2008-05-16 |
EA011392B1 (ru) | 2009-02-27 |
WO2006056696A2 (fr) | 2006-06-01 |
EA200701172A1 (ru) | 2007-10-26 |
AU2005308710A1 (en) | 2006-06-01 |
BRPI0516666A (pt) | 2008-09-16 |
KR20070091120A (ko) | 2007-09-07 |
NO20073026L (no) | 2007-08-27 |
UY29236A1 (es) | 2006-06-30 |
FR2878528A1 (fr) | 2006-06-02 |
TNSN07137A1 (en) | 2008-11-21 |
US7550453B2 (en) | 2009-06-23 |
WO2006056696A3 (fr) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007006241A (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamidas, su preparacion, composiciones que las contienen y su utilizacion. | |
MXPA05007328A (es) | Composiciones que contienen agentes antiacne y el uso de las mismas. | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
TW200505875A (en) | Novel compounds | |
IL182086A0 (en) | Compositions for use against one or more pathogens | |
PL1792927T3 (pl) | Nowy kopolimer blokowy, preparat micelarny i lek przeciwnowotworowy zawierający ten preparat micelarny jako składnik czynny | |
HRP20070374T3 (en) | Formulations comprising ecteinascidin and a disaccharide | |
ZA200702226B (en) | Compounds, compositions containing them, preparations thereof and uses thereof II | |
JO2578B1 (en) | Compounds Theophene benzimidazole | |
UA88956C2 (ru) | Синергическая фунгицидная комбинация действующих веществ | |
TW200510344A (en) | Aryl-heteroaromatic products, compositions comprising them and use | |
IL164440A0 (en) | New pharmaceutical composition containing fibanserin polymorph a | |
MX2007006042A (es) | Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion. | |
TW200744612A (en) | New combination | |
BRPI0417950A (pt) | composições farmacêuticas | |
IL181216A0 (en) | 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same | |
TNSN07241A1 (en) | Substituted pyrroles, compositions containing same, method for making same and use thereof | |
SI1729794T1 (sl) | Farmacevtski pripravek, ki vsebuje sulfobetain, ki nima lastnosti detergenta | |
TW200633717A (en) | Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents | |
RS20050429A (en) | Combination medicament | |
PL377303A1 (pl) | Związki diterpenoidowe, ich kompozycje i ich zastosowanie jako środków przeciwnowotworowych lub przeciwgrzybiczych | |
EA200870565A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение | |
MXPA05012605A (es) | Composiciones que comprenden compuestos de gastrina y sus usos en la diabetes. | |
GEP20084546B (en) | Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent | |
TNSN08442A1 (en) | 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |